HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katsuhisa Ioriya Selected Research

SMP 500

10/2002Effect of SMP-500, a novel acyl-CoA:cholesterol acyltransferase inhibitor, on serum cholesterol level and LDL cholesterol clearance in hamsters with induced hyperlipidemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katsuhisa Ioriya Research Topics

Disease

2Hyperlipidemias (Hyperlipidemia)
04/2010 - 10/2002
1Type 2 Diabetes Mellitus (MODY)
03/2016
1Hyperlipoproteinemia Type III (Broad Beta Disease)
04/2010
1Hypercholesterolemia
10/2002

Drug/Important Bio-Agent (IBA)

2LDL CholesterolIBA
04/2010 - 10/2002
1Sitagliptin Phosphate (Januvia)FDA Link
03/2016
1Blood Glucose (Blood Sugar)IBA
03/2016
1repaglinide (Prandin)FDA Link
03/2016
1SaltsIBA
04/2010
1SodiumIBA
04/2010
1oxidized low density lipoproteinIBA
04/2010
1Proteins (Proteins, Gene)FDA Link
04/2010
1Hypolipidemic Agents (Antihyperlipidemics)IBA
04/2010
1LDL Receptors (LDL Receptor)IBA
04/2010
1SMP 500IBA
10/2002
1Sterol O-AcyltransferaseIBA
10/2002
1CholesterolIBA
10/2002

Therapy/Procedure

1Therapeutics
03/2016
1Exercise Therapy (Therapy, Exercise)
03/2016